Directors of the California stem cell agency this afternoon made the first installment on a $242 million effort to drive stem cell research into the clinic.
The CIRM board approved $1.8 million for 19 planning grants for a $240 million disease team round to be awarded next year. Seventeen applications were rejected. Five of the awards had conditions that must be met before they could continue in the disease team competition.
Both academic and business researchers could compete for the grants.
UCLA researchers John Adams and Chia Soo were unsuccessful in asking the board to reverse a negative decision on their planning grant application.
Here is a list of the researchers and a link to the CIRM news release.
No comments:
Post a Comment